Adding the drug enzalutamide to standard hormone therapy reduced the risk of premature death by more than 40% in patients ...

A powerful new drug combo has yielded a major breakthrough for men battling an aggressive form of prostate cancer, ...

Senegal has launched a nationwide, multisectoral response to tackle a growing outbreak of Rift Valley fever (RVF), warning ...

Men with suspected prostate cancer will be able to get a diagnosis on the NHS within a day, under “game-changing” new trials.

Discover how CD8+ T cell proliferation insights could enhance cancer immunotherapies and predict patient responses.

[DAKAR, LONDON, SciDev.Net] Senegal has launched a nationwide, multisectoral response to tackle a growing outbreak of Rift Valley fever (RVF), warning affected communities against risky ...

The ability of immune cells—particularly CD8+ T cells—to launch a rapid burst of proliferation inside tumors is key to the ...

The ability of immune cells-particularly CD8+ T cells-to launch a rapid burst of proliferation inside tumors is key to the ...

Daiichi Sankyo Company, Limited ( OTCPK:DSNKY) Discusses ESMO 2025 Highlights With Focus on Key Breast Cancer Trial Data and Regulatory Submissions October 21, 2025 8:00 AM EDT ...

The firm hopes to exploit its first-mover advantage in the OTC space following de novo clearance for an at-home PCR test to detect sexually transmitted infections.

Growing consensus is emerging that artificial intelligence (AI) may assist biotechnology and life sciences companies to draft ...